Gaugene

A high-tech company dedicated to providing excellent hematology testing instruments, reagents and services for in vitro diagnostic users.

Market cap

Enterprise valuation

Beijing China (HQ)

Date	Investors	Amount	Round
Aug 2018	Highlight Capital Med-Fine Capital	CNY20.2m	Seed
Jan 2020	E-Town Capital	N/A	Seed
Aug 2020	E-Town Capital Shengyu Investment	CNY100m	Series A
Apr 2021	Qiming Venture Partners	CNY30.0m Valuation: CNY500m	Series A
Jul 2022*	Tao Capital Partners Qiming Venture Partners Guangdong Hybribio Biotech Guangzhou Anbiping Pharmaceutical Technology Fortune Venture Capital Huihe Capital	CNY100m	Series B
Total Funding		$34.4m

Tech stackLearn more about the technologies and tools that this company uses.

Recent News about Gaugene